公开(公告)号：US20220105027A1

公开(公告)日：2022-04-07

申请号：US17273392

申请日：2019-09-06

申请人： Teva Pharmaceutical Industries Ltd.

发明人： Prakash SUNDARAMURTHI ,  Ivana MIJAKOVAC ,  Andrea RASIC ,  Iva TUNJIC

IPC分类号： A61K9/00 ,  A61K31/566 ,  A61K47/10 ,  A61K31/255 ,  A61K47/20 ,  A61K47/02

摘要： The disclosure is directed to medroxyprogesterone compositions suitable for subcutaneous injection comprising about 260 mg/ml to 440 mg/ml medroxyprogesterone acetate, about 0.6 mg/ml to 1.5 mg/ml docusate sodium and, polyethylene glycol. Methods of using these compositions are also described.